Oophorectomy: The debate between ovarian conservation and elective oophorectomy

Menopause

Volumn 20, Issue 1, 2013, Pages 110-114

  Erekson, Elisabeth A ^a   Martin, Deanna K ^a   Ratner, Elena S ^b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive function; Oophorectomy; Osteoporosis; Ovarian cancer prevention; Sexual function

Indexed keywords

ESTRADIOL; ESTROGEN;

BILATERAL SALPINGOOOPHORECTOMY; BONE DENSITY; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; DRUG WITHDRAWAL; ELECTIVE OOPHORECTOMY; ELECTIVE SURGERY; ESTRADIOL BLOOD LEVEL; HAZARD RATIO; HEART DISEASE; HIP FRACTURE; HUMAN; HYSTERECTOMY; LIFE EXPECTANCY; OSTEOPOROSIS; OVARIAN CONSERVATION; OVARIECTOMY; OVARY CANCER; OVARY FUNCTION; PHYSICIAN; POSTOPERATIVE HEMORRHAGE; PREMENOPAUSE; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SALPINGOOOPHORECTOMY; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SURGICAL RISK; SURGICAL TECHNIQUE;

ANXIETY; COGNITION DISORDERS; FEMALE; HEART DISEASES; HUMANS; HYSTERECTOMY; OSTEOPOROSIS; OVARIAN NEOPLASMS; OVARIECTOMY; RISK FACTORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SURGICAL PROCEDURES, ELECTIVE;

EID: 84872055462     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31825a27ab     Document Type: Review

References (45)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Lowder JL, Oliphant SS, Ghetti C, Burrows LJ, Meyn LA, Balk J. Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004. Obstet Gynecol 2010;202:538.e1-e9.
3. ACOG Committee on Practice BulletinsYGynecology. ACOG practice bulletin no. 89. Elective and risk-reducing salpingo-oophorectomy. Obstet Gynecol 2008;111:231-241.
4. Loft A, Lidegaard O, Tabor A. Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up. Br J Obstet Gynaecol 1997; 104:1296-1301.
5. Hankinson SE, Hunter DJ, Colditz GA, et al. Tubal ligation, hysterectomy, and risk of ovarian cancer: a prospective study. JAMA 1993; 270:2813-2818.
6. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 2005;106:219-226.
7. Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study. Obstet Gynecol 2009;113:1027-1037.
8. Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009;16:15-23.
9. Howard BV, Kuller L, Langer R, et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy. Circulation 2005; 111:1462-1470.
10. Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006;7:821-828.
11. Henderson VW, Sherwin BB. Surgical versus natural menopause: cognitive issues. Menopause 2007;14:572-579.
12. Phung TK, Waltoft BL, Laursen TM, et al. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement Geriatr Cogn Disord 2010;30:43-50.
13. Farrag AF, Khedr EM, Abdel-Aleem H, Rageh TA. Effect of surgical menopause on cognitive functions. Dement Geriatr Cogn Disord 2002;13: 193-198.
14. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074-1083.
15. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17: 485-495.
16. Melton LJ 3rd, Khosla S, Malkasian GD, Achenbach SJ, Oberg AL, Riggs BL. Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res 2003;18:900-905.
17. Richelson LS, Wahner HW, Melton LJI, Riggs BL. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 1984;311:1273-1275.
18. Karim R, Dell RM, Greene DF, Mack WJ, Gallagher JC, Hodis HN. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization. Menopause 2011;18:1172-1177.
19. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 1996;97:14-21.
20. Finch A, Metcalfe KA, Chiang JK, et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol 2011;121:163-168.
21. Celik H, Gurates B, Yavuz A, Nurkalem C, Hanay F, Kavak B. The effect of hysterectomy and bilaterally salpingo-oophorectomy on sexual function in post-menopausal women. Maturitas 2008;61:358-363.
22. Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006;13:46-56.
23. Nappi RE. Menopause and sexuality: prevalence of symptoms and impact on quality of life. Maturitas 2009;63:138.
24. Judd HL, Judd GE, Lucas WE, Yen SS. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 1974;39:1020-1024.
25. Judd HL. Hormonal dynamics associated with the menopause. Clin Obstet Gynecol 1976;19:775.
26. ACOG Committee on Practice BulletinsYGynecology. ACOG practice bulletin no. 119. Female sexual dysfunction. Obstet Gynecol 2011;117: 996-1007.
27. SEER cancer statistics review, 1975-2008. Bethesda, MD: National Cancer Institute. 2011. Updated November 10, 2011; cited December 2011. Available at: http://seer.cancer.gov/csr/1975-2008/.
28. Sightler SE, Boike GM, Estape RE, Averette HE. Ovarian cancer in women with prior hysterectomy: a 14-year experience at the University of Miami. Obstet Gynecol 1991;78:681-684.
29. Schwartz PE. The role of prophylactic oophorectomy in the avoidance of ovarian cancer. Int J Gynaecol Obstet 1992;39:175-184.
30. Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010;304:967-975.
31. Kauff ND, Domchek SM, Friebel TM, et al. Risk-reducing salpingooophorectomy for the prevention of BRCA1-and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 2008;26:1331-1337.
32. Hildreth NG, Kelsey JL, LiVolsi VA, et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981;114:398-405.
33. Carlson KJ, Skates SJ, Singer DE. Screening for ovarian cancer. Ann Intern Med 1994;121:124-132.
34. Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 2011;305: 2295-2303.
35. Partridge E, Kreimer A, Greenlee R, et al. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol 2009; 113:775-782.
36. Rossing M, Wicklund K, Cushing Haugen K, Weiss N. Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst 2010;102:222-229.
37. Allison MA, Manson JE, Langer RD, et al. Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative Coronary Artery Calcium Study. Menopause 2008;15:639-647.
38. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density. JAMA 2003;290: 1729-1738.
39. The North American Menopause Society. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010;17:25-54.
40. Berek JS, Chalas E, Edelson M, et al. Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. Obstet Gynecol 2010;116:733-743.
41. Beard RW, Kennedy RG, Gangar KF, et al. Bilateral oophorectomy and hysterectomy in the treatment of intractable pelvic pain associated with pelvic congestion. Br J Obstet Gynaecol 1991;98:988-992.
42. Cronje WH, Vashisht A, Studd JWW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 2004;19:2152-2155.
43. Farquhar CM, Harvey SA, Yu Y, Sadler L, Stewart AW. A prospective study of 3 years of outcomes after hysterectomy with and without oophorectomy. Obstet Gynecol 2006;194:711-717.
44. Madalinska J, Hollenstein J, Bleiker E, et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 2005;23:6890-6898.
45. Tiller K, Meiser B, Butow P, et al. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study. Gynecol Oncol 2002;86:212-219.